Tekla Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Tekla Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-302,945	Closed	-$21.7M	–	186
2022 Q2	$21.7M	Sell	302,945 -78,625	-21%	-$5.75M	0.85%	30
2022 Q1	$30.9M	Sell	381,570 -21,517	-5%	-$1.82M	1.08%	27
2021 Q4	$41.4M	Buy	403,087 +159,454	+65%	+$15.3M	1.33%	24
2021 Q3	$21.3M	Hold	243,633	–	–	0.69%	44
2021 Q2	$21.8M	Sell	243,633 -29,014	-11%	-$2.45M	0.71%	39
2021 Q1	$20.7M	Buy	272,647 +77,511	+40%	+$5.84M	0.71%	38
2020 Q4	$13.3M	Buy	195,136 +87,135	+81%	+$5.43M	0.47%	62
2020 Q3	$5.74M	Hold	108,001	–	–	0.22%	102
2020 Q2	$6.29M	Hold	108,001	–	–	0.24%	86
2020 Q1	$4.26M	Sell	108,001 -7,841	-7%	-$458K	0.19%	97
2019 Q4	$6.89M	Buy	115,842 +69,860	+152%	+$3.76M	0.26%	83
2019 Q3	$2.45M	Buy	45,982 +16,955	+58%	+$870K	0.11%	127
2019 Q2	$1.48M	Hold	29,027	–	–	0.06%	144
2019 Q1	$1.5M	Buy	+29,027	New	+$1.41M	0.06%	141

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tekla Capital Management's SYNH Position: Q3 2022 in Review

Tekla Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 302,945 shares — an estimated $21.7M sold.

Tekla Capital Management first reported a position in SYNH in Q1 2019 and held it in 14 quarters. The position peaked at $41.4M in Q4 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Tekla Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Tekla Capital Management sold 302,945 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $21.7M.
Tekla Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2019 and held it in 14 quarters.
Tekla Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $41.4M in Q4 2021.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Tekla Capital Management's 13F filing for Q3 2022, filed 1 Nov 2022.